Related Experiment Videos
Locally advanced breast cancer.
1Division of Medical Oncology, Treviglio Hospital, Treviglio, Italy. sandro.barni@ospedale.treviglio.bg.it
Current Opinion in Obstetrics & Gynecology
|February 24, 2006
Summary
Treatment for locally advanced breast cancer combines surgery, radiation, and systemic therapy. Recent advances include taxanes and trastuzumab, improving patient outcomes and offering new therapeutic strategies.
Area of Science:
- Oncology
- Breast Cancer Research
- Clinical Trials
Background:
- Locally advanced breast cancer (LABC) necessitates a multimodal treatment strategy.
- Effective management integrates surgery, radiotherapy, and systemic therapies.
Purpose of the Study:
- To review recent advancements in LABC research over the past year.
- To evaluate progress in general strategies, taxane therapy, trastuzumab use, and prognostic factors for LABC.
Main Methods:
- Review of clinical and experimental studies on LABC.
- Focus on specific therapeutic agents and prognostic indicators.
Main Results:
- Multimodality treatment, including chemotherapy, mastectomy, and radiation, is crucial for LABC.
- Taxanes enhance response compared to anthracyclines; trastuzumab shows efficacy in monotherapy or combination.
- Hormonal therapy is indicated for estrogen-receptor-positive cases.
Conclusions:
- New technologies and targeted therapies, alongside established approaches, are improving LABC treatment.
- Potential for enhanced operability, safety, and improved survival rates for LABC patients.